MicroRNA as potential modulators in chemoresistant high-grade gliomas

Journal of Clinical Neuroscience

Volumn 21, Issue 3, 2014, Pages 395-400

  Low, Sharon Yin Yee ^a   Ho, Yoon Khei ^b   Too, Heng Phon ^b   Yap, Celestial Therese ^b   Ng, Wai Hoe ^a  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Chemoresistance; Gliomas; MicroRNA; Temozolomide

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MICRORNA; TEMOZOLOMIDE;

ARTICLE; BLOOD BRAIN BARRIER; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; DISEASE COURSE; DNA REPAIR; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GLIOBLASTOMA; GLIOMA; GLIOMA STEM CELL; HUMAN; ONCOGENE; PRIORITY JOURNAL; STEM CELL NICHE; TUMOR MICROENVIRONMENT;

CHEMORESISTANCE; GLIOMAS; MICRORNA; TEMOZOLOMIDE;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; DACARBAZINE; DRUG RESISTANCE, NEOPLASM; GLIOMA; HUMANS; MICRORNAS; NEOPLASM GRADING;

EID: 84895078644     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2013.07.033     Document Type: Review

References (89)

1. D. Ricard, A. Idbaih, and F. Ducray et al. Primary brain tumours in adults Lancet 379 2012 1984 1996
2. R. Stupp, W.P. Mason, and M.J. van den Bent et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
3. E.G. Van Meir, C.G. Hadjipanayis, and A.D. Norden et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma CA Cancer J Clin 60 2010 166 193
4. P. Gonzalez-Gomez, P. Sanchez, and H. Mira MicroRNA as regulators of neural stem cell-related pathways in glioblastoma multiforme Mol Neurobiol 44 2011 235 249
5. K.E. Allen, and G.J. Weiss Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics Mol Cancer Ther 9 2010 3126 3136
6. D.P. Bartel MicroRNA: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
7. S. Luan, L. Sun, and F. Huang MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251 Arch Med Res 41 2010 67 74
8. J.D. Turner, R. Williamson, and K.K. Almefty et al. The many roles of microRNA in brain tumor biology Neurosurg Focus 28 2010 E3
9. N. Lynam-Lennon, S.G. Maher, and J.V. Reynolds The roles of microRNA in cancer and apoptosis Biol Rev Camb Philos Soc 84 2009 55 71
10. L.R. Corsini, G. Bronte, and M. Terrasi et al. The role of microRNA in cancer: diagnostic and prognostic biomarkers and targets of therapies Expert Opin Ther Targets 16 2012 S103 S109
11. J. Silber, C.D. James, and J.G. Hodgson MicroRNA in gliomas: small regulators of a big problem Neuromolecular Med 11 2009 208 222
12. C.L. Bartels, and G.J. Tsongalis MicroRNA: novel biomarkers for human cancer Clin Chem 55 2009 623 631
13. H. Dong, H. Siu, and L. Luo et al. Investigation gene and microRNA expression in glioblastoma BMC Genomics 11 2010 S16
14. S. Wuchty, D. Arjona, and A. Li et al. Prediction of associations between microRNA and gene expression in glioma biology PLoS ONE 6 2011 e14681
15. T. Fojo Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and microRNA Drug Resist Updat 10 2007 59 67
16. P.E. Blower, J.H. Chung, and J.S. Verducci et al. MicroRNA modulate the chemosensitivity of tumor cells Mol Cancer Ther 7 2008 1 9
17. N. Lynam-Lennon, S.G. Maher, and J.V. Reynolds The roles of microRNA in cancer and apoptosis Biol Rev Camb Philos Soc 84 2009 55 71
18. S.S. Agarwala, and J.M. Kirkwood Temozolomide, a novel alkylating agent with activity in the central nervous system, may improve the treatment of advanced metastatic melanoma Oncologist 5 2000 144 151
19. W.K. Yung Temozolomide in malignant gliomas Semin Oncol 27 2000 27 34
20. J. Zhang, M.F. Stevens, and T.D. Bradshaw Temozolomide: mechanisms of action, repair and resistance Curr Mol Pharmacol 5 2012 102 114
21. R. Stupp, M.E. Hegi, and M.R. Gilbert et al. Chemoradiotherapy in malignant glioma: standard of care and future directions J Clin Oncol 25 2007 4127 4136
22. M.E. Hegi, A.C. Diserens, and T. Gorlia et al. MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003
23. M. Esteller, M. Toyota, and M. Sanchez-Cespedes et al. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis Cancer Res 60 2000 2368 2371
24. R. Martinez, G. Schackert, and R. Yaya-Tur et al. Frequent hypermethylation of the DNA repair gene MGMT in long-term survivors of glioblastoma multiforme J Neurooncol 83 2007 91 93
25. A.E. Pegg Repair of O(6)-alkylguanine by alkyltransferases Mutat Res 462 2000 83 100
26. S.C. Naumann, W.P. Roos, and E. Jost et al. Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53 Br J Cancer 100 2009 322 333
27. R. Stupp, and M.E. Hegi Methylguanine methyltransferase testing in glioblastoma: when and how? J Clin Oncol 25 2007 1459 1460
28. S. Kohsaka, L. Wang, and K. Yachi et al. STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression Mol Cancer Ther 11 2012 1289 1299
29. B. Dai, J. Meng, and M. Peyton et al. STAT3 mediates resistance to MEK inhibitor through microRNA miR-17 Cancer Res 71 2011 3658 3668
30. K. Ujifuku, N. Mitsutake, and S. Takakura et al. MiR-195, miR-455-3p and miR-10a(*) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells Cancer Lett 296 2010 241 248
31. O. Slaby, R. Lakomy, and P. Fadrus et al. MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients Neoplasma 57 2010 264 269
32. M. De Salvo, G. Maresca, and I. D'Agnano et al. Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells Int J Radiat Biol 87 2011 518 533
33. T. Fukushima, H. Takeshima, and H. Kataoka Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT Anticancer Res 29 2009 4845 4854
34. S. Cai, Y. Xu, and R.J. Cooper et al. Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents Cancer Res 65 2005 3319 3327
35. D.S. Middlemas, C.F. Stewart, and M.N. Kirstein et al. Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models Clin Cancer Res 6 2000 998 1007
36. J.R. Silber, M.S. Bobola, and A. Blank et al. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress Clin Cancer Res 8 2002 3008 3018
37. C.L. Cheng, S.P. Johnson, and S.T. Keir et al. Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair-deficient malignant glioma xenograft Mol Cancer Ther 4 2005 1364 1368
38. J.A. Maxwell, S.P. Johnson, and R.E. McLendon et al. Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma Clin Cancer Res 14 2008 4859 4868
39. N. Auger, J. Thillet, and K. Wanherdrick et al. Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell line Mol Cancer Ther 5 2006 2182 2192
40. N. Gaspar, L. Marshall, and L. Perryman et al. MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature Cancer Res 70 2010 9243 9252
41. C. Lu, and A. Shervington Chemoresistance in gliomas Mol Cell Biochem 312 2008 71 80
42. K. Polyak, and W.C. Hahn Roots and stems: stem cells in cancer Nat Med 12 2006 296 300
43. T. Denysenko, L. Gennero, and M.A. Roos et al. Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies Cell Biochem Funct 28 2010 343 351
44. R. Yamada, and I. Nakano Glioma stem cells: their role in chemoresistance World Neurosurg 77 2012 237 240
45. J.M. Heddleston, Z. Li, and R.E. McLendon et al. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype Cell Cycle 8 2009 3274 3284
46. A. Murat, E. Migliavacca, and T. Gorlia et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma J Clin Oncol 26 2008 3015 3024
47. L.C. Laurent, J. Chen, and I. Ulitsky et al. Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence Stem Cells 26 2008 1506 1516
48. M.R. Suh, Y. Lee, and J.Y. Kim et al. Human embryonic stem cells express a unique set of microRNA Dev Biol 270 2004 488 498
49. D.A. Card, P.B. Hebbar, and L. Li et al. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells Mol Cell Biol 28 2008 6426 6438
50. N. Xu, T. Papagiannakopoulos, and G. Pan et al. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells Cell 137 2009 647 658
51. R.R. Chivukula, and J.T. Mendell Abate and switch: miR-145 in stem cell differentiation Cell 137 2009 606 608
52. S. Bao, Q. Wu, and R.E. McLendon et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response Nature 444 2006 756 760
53. G. Liu, X. Yuan, and Z. Zeng et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma Mol Cancer 5 2006 67
54. Z. Huang, L. Cheng, and O.A. Guryanova et al. Cancer stem cells in glioblastoma-molecular signaling and therapeutic targeting Protein Cell 1 2010 638 655
55. H. Xia, and K.M. Hui MicroRNA involved in regulating epithelial- mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics Cancer Gene Ther 19 2012 723 730
56. L. Shi, S. Zhang, and K. Feng et al. MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis Int J Oncol 40 2012 119 129
57. S. Zhang, Y. Wan, and T. Pan et al. MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide J Mol Neurosci 47 2012 346 356
58. M.V. Blagosklonny Carcinogenesis, cancer therapy and chemoprevention Cell Death Differ 12 2005 592 602
59. C. Calatozzolo, M. Gelati, and E. Ciusani et al. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma J Neurooncol 74 2005 113 121
60. D.A. Chistiakov, and V.P. Chekhonin Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential Eur J Pharmacol 684 2012 8 18
61. K. Toth, M.M. Vaughan, and N.S. Peress et al. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors Am J Pathol 149 1996 853 858
62. Y. An, and W.M. Ongkeko ABCG2: the key to chemoresistance in cancer stem cells? Expert Opin Drug Metab Toxicol 5 2009 1529 1542
63. W.Q. Li, Y.M. Li, and B.B. Tao et al. Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance Med Sci Monit 16 2010 HY27 HY30
64. H.M. Jeon, Y.W. Sohn, and S.Y. Oh et al. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2 Cancer Res 71 2011 3410 3421
65. A. Murat, E. Migliavacca, and T. Gorlia et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma J Clin Oncol 26 2008 3015 3024
66. M.L. Wong, A.H. Kaye, and C.M. Hovens Targeting malignant glioma survival signalling to improve clinical outcomes J Clin Neurosci 14 2007 301 308
67. M. Nozaki, M. Tada, and H. Kobayashi et al. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression Neurooncology 1 1999 124 137
68. F. Bunz, A. Dutriaux, and C. Lengauer et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage Science 282 1998 1497 1501
69. B.K. Vogelstein, and K.W. Kinzler Cancer genes and the pathways they control Nat Med 10 2004 789 799
70. C.J. Sherr Principles of tumor suppression Cell 116 2004 235 246
71. E.M. Duerr, B. Rollbrocker, and Y. Hayashi et al. PTEN mutations in gliomas and glioneuronal tumors Oncogene 16 1998 2259 2264
72. H. Ohgaki, and P. Kleihues Genetic pathways to primary and secondary glioblastoma Am J Pathol 170 2007 1445 1453
73. L.D. Mayo, J.E. Dixon, and D.L. Durden et al. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy J Biol Chem 277 2002 5484 5489
74. K. Tanaka, I. Babic, and D. Nathanson et al. Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance Cancer Discov 1 2011 524 538
75. B. Kefas, J. Godlewski, and L. Comeau et al. MicroRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma Cancer Res 68 2008 3566 3572
76. M. Shao, S. Rossi, and B. Chelladurai et al. PDGF induced microRNA alterations in cancer cells Nucleic Acids Res 39 2011 4035 4047
77. T. Papagiannakopoulos, A. Shapiro, and K.S. Kosik MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells Cancer Res 68 2008 8164 8172
78. H.J. Kwak, Y.J. Kim, and K.R. Chun et al. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas Oncogene 30 2011 2433 2442
79. M.F. Corsten, R. Miranda, and R. Kasmieh et al. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas Cancer Res 67 2007 8994 9000
80. L. Shi, J. Chen, and J. Yang et al. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity Brain Res 1352 2010 255 264
81. Y. Li, W. Li, and Y. Yang et al. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme Brain Res 1286 2009 13 18
82. J.D. Huber, R.D. Egleton, and T.P. Davis Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier Trends Neurosci 24 2001 719 725
83. M.F. Bear, B.W. Connors, and M.A. Paradiso Neuroscience: exploring the brain 2006 Lippincott Williams and Wilkins Baltimore
84. C. Krakstad, and M. Chekenya Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics Mol Cancer 9 2010 135
85. R. Garzon, G. Marcucci, and C.M. Croce Targeting microRNA in cancer: rationale, strategies and challenges Nat Rev Drug Discov 9 2010 775 789
86. S. Catuogno, C.L. Esposito, and C. Quintavalle et al. Nucleic acids in human glioma treatment: innovative approaches and recent results J Signal Transduct 2012 2012 735135
87. X. Wang, L. Han, and A. Zhang et al. Adenovirus-mediated shRNA for co-repression of miR-221 and miR-222 expression and function in glioblastoma cells Oncol Rep 25 2011 97 105
88. C.E. Thomas, A. Ehrhardt, and M.A. Kay Progress and problems with the use of viral vectors for gene therapy Nat Rev Genet 4 2003 346 358
89. Y.P. Yang, Y. Chien, and G.Y. Chiou et al. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI Biomaterials 33 2012 1462 1476